FINANCE ROUNDUP: Venture Cash Flows To Biotech, IPOs Stagnate
This article was originally published in Scrip
Executive Summary
A surprising slide in global stock indices on Monday did not stop venture capital investors from keeping their commitments to private biotechnology companies during the last full week of August, but no new initial public offerings launched in the US between Aug. 24 and 28.